(株)ファンペップの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4881/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/12/24 | 日証協 | 417,600株 | -15.21% | 39,400株 | +885% | 752,129株 | -6.87% | 31,370株 | -42.75% |
2021/12/17 | 日証協 | 492,500株 | -13.15% | 4,000株 | -97.15% | 807,579株 | -0.96% | 54,799株 | -56.82% |
2021/12/10 | 日証協 | 567,100株 | +43.53% | 140,400株 | -46.68% | 815,380株 | +15.77% | 126,900株 | -24.42% |
2021/12/03 | 日証協 | 395,100株 | -0.93% | 263,300株 | +1059.91% | 704,280株 | -0.03% | 167,900株 | +642.92% |
2021/11/26 | 日証協 | 398,800株 | -0.2% | 22,700株 | -71.66% | 704,480株 | +0.67% | 22,600株 | -22.6% |
2021/11/19 | 日証協 | 399,600株 | -4.83% | 80,100株 | +265.75% | 699,780株 | +0.81% | 29,200株 | +11.01% |
2021/11/05 | 日証協 | 435,700株 | +0.16% | 35,200株 | -67.74% | 691,585株 | +0.19% | 8,720株 | -39.02% |
2021/10/29 | 日証協 | 435,000株 | -3.01% | 109,100株 | +347.13% | 690,265株 | -1.64% | 14,300株 | -68.08% |
2021/10/22 | 日証協 | 448,500株 | -10.26% | 24,400株 | -64.01% | 701,765株 | +0.06% | 44,801株 | +96.34% |
2021/10/15 | 日証協 | 499,800株 | -10.69% | 67,800株 | -0.15% | 701,346株 | -3.79% | 22,818株 | -34.81% |
2021/10/08 | 日証協 | 559,600株 | +4.36% | 67,900株 | -39.54% | 728,946株 | +5.1% | 35,000株 | -55.81% |
2021/10/01 | 日証協 | 536,200株 | +18.11% | 112,300株 | +289.93% | 693,546株 | +3.31% | 79,200株 | +700% |
2021/09/24 | 日証協 | 454,000株 | -3.14% | 28,800株 | -63.12% | 671,346株 | -3.45% | 9,900株 | -61.02% |
2021/09/17 | 日証協 | 468,700株 | -21.46% | 78,100株 | -5.45% | 695,346株 | -9.04% | 25,400株 | -20.19% |
2021/09/10 | 日証協 | 596,800株 | -0.7% | 82,600株 | -10.31% | 764,445株 | +1.73% | 31,826株 | -23.86% |
2021/09/03 | 日証協 | 601,000株 | +0.64% | 92,100株 | -70.7% | 751,420株 | -5.66% | 41,800株 | -65.34% |
2021/08/27 | 日証協 | 597,200株 | +16.85% | 314,300株 | +159.54% | 796,520株 | +10.12% | 120,600株 | +23.26% |
2021/08/20 | 日証協 | 511,100株 | +9.3% | 121,100株 | +580.34% | 723,320株 | +4.39% | 97,845株 | +773.54% |
2021/08/13 | 日証協 | 467,600株 | -8.31% | 17,800株 | -77.75% | 692,910株 | -6.05% | 11,201株 | -84.49% |
※株式分割は考慮していませんのでご注意ください。
Page Top